These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17054653)

  • 1. Testosterone shortens QT interval on ECG in both genders and may underlie lower incidence of torsades de pointes in males.
    Koivisto AP
    Acta Physiol (Oxf); 2006; 188(3-4):151. PubMed ID: 17054653
    [No Abstract]   [Full Text] [Related]  

  • 2. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs.
    Fülöp L; Bányász T; Szabó G; Tóth IB; Bíró T; Lôrincz I; Balogh A; Petô K; Mikó I; Nánási PP
    Acta Physiol (Oxf); 2006; 188(3-4):163-71. PubMed ID: 17054656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone.
    Takahara A; Nakamura Y; Sugiyama A
    Eur J Pharmacol; 2008 Oct; 596(1-3):127-31. PubMed ID: 18786527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report].
    Okada T; Miyata S; Hashimoto K; Maie K; Mochizuki S
    J Cardiol; 2007 Jul; 50(1):83-8. PubMed ID: 17685032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
    Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA
    Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pause-dependent Torsade de Pointes following acute myocardial infarction].
    Tomcsányi J; Somlói M; Vecsey T
    Orv Hetil; 2003 Jul; 144(30):1489-91. PubMed ID: 14569679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular profile of the canine torsades de pointes arrhythmia model assessed by echocardiographic and haemodynamic methods.
    Takahara A; Sugiyama A; Satoh Y; Iwasaki H; Nakamura Y; Hashimoto K
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):35-40. PubMed ID: 17577314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postaortic valve replacement bradycardia induced torsades de pointes.
    Amchentsev A; Haq SA; Holt JJ; Khan A; Gelles J; Kassotis J
    Angiology; 2008; 59(1):111-3. PubMed ID: 18319232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe primary hypothyroidism presenting with torsades de pointes.
    Kandan SR; Saha M
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22987900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
    Kawabata M; Hirao K; Takeshi S; Sakurai K; Inagaki H; Hachiya H; Isobe M
    J Electrocardiol; 2008; 41(2):117-22. PubMed ID: 18328336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Images in cardiology. Pacemaker induced torsades de pointes tachycardia.
    Böhm A; Pintér A; Préda I
    Heart; 1998 Nov; 80(5):466. PubMed ID: 9930045
    [No Abstract]   [Full Text] [Related]  

  • 15. The Clue Is in the U Wave: Torsades de Pointes Ventricular Tachycardia in a Hypokalemic Woman on Methadone.
    Fitzpatrick JK; Goldschlager N
    Ann Emerg Med; 2018 Apr; 71(4):473-476. PubMed ID: 29566890
    [No Abstract]   [Full Text] [Related]  

  • 16. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
    Atkinson D; Dunne A; Parker M
    Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex, drugs and arrhythmia: are gender differences in risk of torsades de pointes simply a matter of testosterone?
    James AF; Hancox JC
    Cardiovasc Res; 2003 Jan; 57(1):1-4. PubMed ID: 12504807
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of routine QT interval measurement in rhythm interpretation.
    Hutton DM
    Dynamics; 2008; 19(3):29-33. PubMed ID: 18773713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma.
    Methe H; Hinterseer M; Wilbert-Lampen U; Beckmann BM; Steinbeck G; Kääb S
    Hypertens Res; 2007 Dec; 30(12):1263-6. PubMed ID: 18344633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Torsades de pointes and a prolonged QT interval in the context of a very low-calorie-diet].
    Gómez-Barrado JJ; Turégano S; Polo J; Carreras R
    Rev Esp Cardiol; 2008 Jul; 61(7):780-2. PubMed ID: 18590654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.